EUVIMEDEUVIMED entdecken
Crossref

Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections

Zixuan Zhao iD, Han Feng iD, Xiaohong Zhao, Bowen Xie iD, Tian Xie iD, Qinli Sun iD, Yongzhen Chen iD, Kun Wei, Birui Pan, Peng Wei iD, Xuan Zhong iD, Lei Yuan iD und 3 weitere

Science Immunology · 2026

DOI: 10.1126/sciimmunol.aec5171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Zixuan Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Interleukins, CD8-Positive T-Lymphocytes, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, New Cornerstone Science Foundation Innovative Research Team of High level Local Universities in Shanghai Shanghai Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8 T cells are critical players in immune responses against pathogens. Interleukin-21 (IL-21) is predominantly produced by CD4 T cells and exerts multifaceted effects on CD8 T cell regulation and function. Using Il21 -reporter and Il21 –fate mapping mice, we report that a subpopulation of activated CD8 T cells also produces IL-21 in the context of lymphocytic choriomeningitis virus (LCMV) infection. During the early effector phase of both acute and chronic infections, IL-21–expressing CD8 T cells exhibit substantial proliferative and cytotoxic capacities, with higher levels of interferon-γ (IFN-γ) and granzyme B (GZMB) compared with IL-21 − counterparts. Moreover, CD8 T cell–derived IL-21 played a critical protective role in chronic, but not acute, infection. IL-21 expression in CD8 T cells appeared to be largely restricted to exhausted progenitor T cells during the exhaustion phase of chronic infection. These findings identify IL-21–expressing CD8 T cells as pivotal players in the control of chronic infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InterleukinsCD8-Positive T-LymphocytesLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusPersistent InfectionAnimalsInterleukin-21MiceT-Cell ExhaustionMice, Inbred C57BLChronic Disease

Substanzen

Interleukin-21Interleukins

Autor:innen und Institutionen

  • Institute for Immunology, Tsinghua University, Beijing, China.
  • Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, Zhejiang, China.
  • Shanghai Immune Therapy Institute, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China.

ORCID-Profile: Zixuan Zhao, Han Feng, Bowen Xie, Tian Xie, Qinli Sun, Yongzhen Chen, Peng Wei, Xuan Zhong, Lei Yuan, Xue Bai, Xiaohu Wang, Chen Dong

Förderung

  • National Natural Science Foundation of China
  • New Cornerstone Science Foundation Innovative Research Team of High level Local Universities in Shanghai Shanghai Science and Technology Commission

Zitieren

APA

Zhao, Z., Feng, H., Zhao, X., Xie, B., Xie, T., Sun, Q., Chen, Y., Wei, K., Pan, B., Wei, P., Zhong, X., Yuan, L., Bai, X., Wang, X., & Dong, C. (2026). Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections. Science Immunology. https://doi.org/10.1126/sciimmunol.aec5171

Vancouver

Zhao Z, Feng H, Zhao X, Xie B, Xie T, Sun Q, et al. Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections. Science Immunology. 2026. doi:10.1126/sciimmunol.aec5171

BibTeX
@article{Zhao2026,
  author = {Zhao, Zixuan and Feng, Han and Zhao, Xiaohong and Xie, Bowen and Xie, Tian and Sun, Qinli and Chen, Yongzhen and Wei, Kun and Pan, Birui and Wei, Peng and Zhong, Xuan and Yuan, Lei and Bai, Xue and Wang, Xiaohu and Dong, Chen},
  title = {Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections},
  journal = {Science Immunology},
  year = {2026},
  doi = {10.1126/sciimmunol.aec5171}
}
Kostenlos starten →